0000914190-21-000192.txt : 20210706 0000914190-21-000192.hdr.sgml : 20210706 20210706163427 ACCESSION NUMBER: 0000914190-21-000192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN ALLAN L CENTRAL INDEX KEY: 0000905390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 211074560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-06-30 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0000905390 GOLDSTEIN ALLAN L C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 0 0 0 Common Stock 2021-06-30 4 P 0 125000 0.2 A 1637793 D Stock Option (right to buy) 0.36 2022-06-30 Common Stock 250000 250000 D Stock Option (right to buy) 0.64 2023-03-16 Common Stock 200000 200000 D Stock Option (right to buy) 0.28 2027-09-01 Common Stock 150000 150000 D Stock Option (right to buy) 0.21 2028-07-17 Common Stock 250000 250000 D Stock Option (right to buy) 0.21 2029-05-15 Common Stock 410000 410000 D Stock Option (right to buy) 0.30 2030-06-10 Common Stock 400000 400000 D Convertible Promissory Note (right to buy) 0.12 2019-02-27 2024-02-27 Common Stock 20833 2500.00 D Convertible Promissory Note (right to buy) 0.12 2019-05-13 2024-05-13 Common Stock 20833 2500.00 D Convertible Promissory Note (right to buy) 0.36 2020-10-15 2025-10-15 Common Stock 13920 5000 D Common Stock Warrant (right to buy) 0.18 2019-08-27 2024-02-27 Common Stock 15625 15625 D Common Stock Warrant (right to buy) 0.18 2019-11-13 2024-05-13 Common Stock 15625 15625 D Common Stock Warrant (right to buy) 0.45 2021-04-15 2025-10-15 Common Stock 10440 10440 D Series A Common Stock Warrant (right to buy) 0.24 2021-06-30 4 P 0 93750 0 A 2021-06-30 2023-06-30 Common Stock 93750 93750 D Series B Common Stock Warrant (right to buy) 0.28 2021-06-30 4 P 0 93750 0 A 2021-06-30 2026-06-30 Common Stock 93750 93750 D 100% vested. 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21. 102,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22. 100,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23. /s/ Andrew Nick as Attorney-in-Fact for Allan Goldstein, Ph.D. pursuant to Power of Attorney previously filed. 2021-07-06